Telomere Length Is Predictive of Breast Cancer Risk in BRCA2 Mutation Carriers

Background: Germline BRCA2 mutations increase risk of breast cancer and other malignancies. BRCA2 has been shown to play a role in telomere protection and maintenance. Telomere length (TL) has been studied as a modifying factor for various diseases, including breast cancer. Previous research on TL in BRCA mutation carriers has produced contradicting results. Methods: We measured blood TL, using a high-throughput monochrome multiplex qPCR method, in a well-defined Icelandic cohort of female BRCA2 mutation carriers (n = 169), sporadic breast cancer patients (n = 561), and healthy controls (n = 537). Results: Breast cancer cases had significantly shorter TL than unaffected women (P < 0.0001), both BRCA2 mutation carriers (P = 0.0097) and noncarriers (P = 0.00006). Using exclusively samples acquired before breast cancer diagnosis, we found that shorter telomeres were significantly associated with increased breast cancer risk in BRCA2 mutation carriers [HR, 3.60; 95% confidence interval (CI), 1.17–11.28; P, 0.025] but not in non-carriers (HR,1.40; 95% CI, 0.89–2.22; P, 0.15). We found no association between TL and breast cancer–specific survival. Conclusions: Blood TL is predictive of breast cancer risk in BRCA2 mutation carriers. Breast cancer cases have significantly shorter TL than unaffected women, regardless of BRCA2 status, indicating that samples taken after breast cancer diagnosis should not be included in evaluations of TL and breast cancer risk. Impact: Our study is built on a well-defined cohort, highly accurate methods, and long follow-up and can therefore help to clarify some previously published, contradictory results. Our findings also suggest that BRCA2 has an important role in telomere maintenance, even in normal blood cells. Cancer Epidemiol Biomarkers Prev; 26(8); 1248–54. ©2017 AACR.

[1]  E. Maunsell,et al.  Association of Telomere Length with Breast Cancer Prognostic Factors , 2016, PloS one.

[2]  A. McTiernan,et al.  Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors. , 2014, Journal of the National Cancer Institute.

[3]  R. Eeles,et al.  Lymphocyte Telomere Length Is Long in BRCA1 and BRCA2 Mutation Carriers Regardless of Cancer-Affected Status , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[4]  R. Eeles,et al.  Telomere Length Shows No Association with BRCA1 and BRCA2 Mutation Status , 2014, PloS one.

[5]  M. Urioste,et al.  Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients , 2014, Breast Cancer Research and Treatment.

[6]  R. Cawthon,et al.  Short telomere length, cancer survival, and cancer risk in 47102 individuals. , 2013, Journal of the National Cancer Institute.

[7]  N. Rothman,et al.  Association of leukocyte telomere length with breast cancer risk: nested case-control findings from the Shanghai Women's Health Study. , 2013, American journal of epidemiology.

[8]  Katsumasa Nakamura,et al.  Radiation-associated changes in the length of telomeres in peripheral leukocytes from inpatients with cancer , 2013, International journal of radiation biology.

[9]  M. Szyper-Kravitz,et al.  The effect of chemotherapy on telomere dynamics: clinical results and possible mechanisms , 2013, Leukemia & lymphoma.

[10]  Kathleen Bennett,et al.  A prospective investigation of predictive and modifiable risk factors for breast cancer in unaffected BRCA1 and BRCA2 gene carriers , 2013, BMC Cancer.

[11]  L. Tryggvadottir,et al.  Data quality at the Icelandic Cancer Registry: Comparability, validity, timeliness and completeness , 2012, Acta oncologica.

[12]  Hong Wu,et al.  A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. , 2012, Cancer cell.

[13]  A. Neugut,et al.  Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival , 2012, Breast Cancer Research and Treatment.

[14]  M. Urioste,et al.  Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases , 2012, Journal of Medical Genetics.

[15]  J. Eyfjord,et al.  Dysfunctional telomeres in human BRCA2 mutated breast tumors and cell lines. , 2012, Mutation research.

[16]  A. Venkitaraman,et al.  The Breast Cancer Susceptibility Gene BRCA2 Is Required for the Maintenance of Telomere Homeostasis* , 2011, The Journal of Biological Chemistry.

[17]  J. Jónasson,et al.  Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression , 2011, Breast Cancer Research.

[18]  M. Urioste,et al.  Genetic Anticipation Is Associated with Telomere Shortening in Hereditary Breast Cancer , 2011, PLoS genetics.

[19]  Q. Wei,et al.  Shortened Telomere Length Is Associated with Increased Risk of Cancer: A Meta-Analysis , 2011, PloS one.

[20]  A. Egashira,et al.  Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11 , 2011, Cell.

[21]  R. Pfeiffer,et al.  The Association of Telomere Length and Cancer: a Meta-analysis , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[22]  J. Benítez,et al.  BRCA2 Acts as RAD51 Loader to Facilitate Telomere Replication and Capping , 2010, Nature Structural &Molecular Biology.

[23]  F. Kronenberg,et al.  Telomere length and risk of incident cancer and cancer mortality. , 2010, JAMA.

[24]  J. Murnane,et al.  Telomere loss as a mechanism for chromosome instability in human cancer. , 2010, Cancer research.

[25]  B. Ponder,et al.  Telomere length in prospective and retrospective cancer case-control studies. , 2010, Cancer research.

[26]  J. Ford,et al.  Longer Relative Telomere Length in Blood from Women with Sporadic and Familial Breast Cancer Compared with Healthy Controls , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[27]  M. Nesline,et al.  Telomere length in blood cells and breast cancer risk: investigations in two case–control studies , 2010, Breast Cancer Research and Treatment.

[28]  A. Neugut,et al.  Telomere length, oxidative damage, antioxidants and breast cancer risk , 2009, International journal of cancer.

[29]  D. Hunter,et al.  A Prospective Study of Relative Telomere Length and Postmenopausal Breast Cancer Risk , 2009, Cancer Epidemiology Biomarkers & Prevention.

[30]  Richard M. Cawthon,et al.  Telomere length measurement by a novel monochrome multiplex quantitative PCR method , 2009, Nucleic acids research.

[31]  Göran Roos,et al.  Breast cancer survival is associated with telomere length in peripheral blood cells. , 2008, Cancer research.

[32]  R. Santella,et al.  Short telomere length and breast cancer risk: a study in sister sets. , 2007, Cancer research.

[33]  A. Ashworth,et al.  The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability , 2006, Oncogene.

[34]  J. Eyfjord,et al.  Genomic instability and cancer: networks involved in response to DNA damage. , 2005, Mutation research.

[35]  K. Chin,et al.  In situ analyses of genome instability in breast cancer , 2004, Nature Genetics.

[36]  E. Montgomery,et al.  Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis , 2004, Clinical Cancer Research.

[37]  Ashok R Venkitaraman,et al.  Cancer Susceptibility and the Functions of BRCA1 and BRCA2 , 2002, Cell.

[38]  N. Weng.  Interplay between telomere length and telomerase in human leukocyte differentiation and aging , 2001, Journal of leukocyte biology.

[39]  Margaret A. Strong,et al.  The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability , 2001, Cell.

[40]  Lynda Chin,et al.  Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice , 2000, Nature.

[41]  J. Eyfjörd,et al.  BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability. , 1998, Cancer research.

[42]  A. Jonasdottir,et al.  Identification of a novel splice‐site mutation of the BRCA1 gene in two breast cancer families: Screening reveals low frequency in Icelandic breast cancer patients , 1998, Human mutation.

[43]  J. Eyfjörd,et al.  Study of a single BRCA2 mutation with high carrier frequency in a small population. , 1997, American journal of human genetics.

[44]  J. Eyfjörd,et al.  A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes , 1996, Nature Genetics.

[45]  C B Harley,et al.  Telomere end-replication problem and cell aging. , 1992, Journal of molecular biology.

[46]  L. S. Cram,et al.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.